Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
Hanas JS, Peyton MD, Lerner MR, Lightfoot SA, Deb SJ, Hanas RJ, Vu NT, Kupiec TC, Stowell DE, Brackett DJ, Dubinett SM, Hocker JR. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Invest. 2014 May; 32(4):136-43.
-
Adult
-
Adult
-
Aged
-
Aged
-
Aged, 80 and over
-
Aged, 80 and over
-
Biomarkers, Tumor
-
Biomarkers, Tumor
-
Biopsy
-
Biopsy
-
Carcinoma, Non-Small-Cell Lung
-
Carcinoma, Non-Small-Cell Lung
-
Diagnosis, Differential
-
Diagnosis, Differential
-
Early Detection of Cancer
-
Early Detection of Cancer
-
Female
-
Female
-
Humans
-
Humans
-
Lung Neoplasms
-
Lung Neoplasms
-
Male
-
Male
-
Middle Aged
-
Middle Aged
-
Multiple Pulmonary Nodules
-
Multiple Pulmonary Nodules
-
Neoplasm Staging
-
Neoplasm Staging
-
Predictive Value of Tests
-
Predictive Value of Tests
-
Proteomics
-
Proteomics
-
Retrospective Studies
-
Retrospective Studies
-
Solitary Pulmonary Nodule
-
Solitary Pulmonary Nodule
-
Spectrometry, Mass, Electrospray Ionization
-
Spectrometry, Mass, Electrospray Ionization
-
Tomography, X-Ray Computed
-
Tomography, X-Ray Computed
-
Tumor Burden
-
Tumor Burden